To the Editor—With much anticipation, we have reviewed the recently published Infectious Diseases Society of America (IDSA) and American Society of Tropical Medicine and Hygiene 2017 guidelines for the diagnosis and treatment of neurocysticercosis [1]. We applaud the publication of the first IDSA guidelines dedicated to the management of this disease; however, we would like to note a dosing discrepancy encountered in one of the tables in that publication [1, p. e63].

中文翻译：

---

2017年神经囊尾rc病指南中的抗寄生虫药剂量差异

致编辑-我们怀着很大的期望，回顾了最近出版的美国传染病学会（IDSA）和美国热带医学与卫生学会2017年关于诊断和治疗神经囊虫病的指南[1]。我们赞扬发布了专门针对该疾病管理的第一份IDSA指南；但是，我们要指出的是该出版物[1，p。1]中的一个表中遇到的剂量差异。e63]。